Abstract
Background Both stroke and psychosis are independently associated with high levels of disability. However, psychosis in the context of stroke has received remarkably little interest from clinicians and researchers. To date there are currently no population studies on their joint prevalence and association.
Methods We estimated the prevalence of i) probable psychosis in stroke and, ii) stroke in probable psychosis using four nationally representative cross-sectional psychiatric epidemiological studies: two from high-income countries (United Kingdom and United States) and two from middle-income countries (Chile and Colombia) and, subsequently, a combined dataset from all four countries. We also tested the statistical association between stroke and psychosis using single and multi-level regression models to estimate the unadjusted association between stroke and psychosis, and the association adjusted for potential demographic confounders.
Results Across the combined countries dataset the prevalence of probable psychosis in stroke was 3.81% [95% CIs 2.34 – 5.82] and stroke in probable psychosis was 3.15% [95% CIs 1.94 – 4.83] suggesting approximately 1 in 26 people with probable psychosis have stroke and 1 in 32 people with stroke have probable psychosis. The adjusted association between stroke and probable psychosis from the combined dataset was estimated at OR = 3.32 [95% CIs 2.05 - 5.38]. We also examined the association between stroke and paranoia, hallucinated voices, and thought passivity delusion, and although we found significant variation in the reliability and strength of association across countries, all three psychotic symptoms were associated with stroke in the unadjusted and adjusted analyses in the combined countries dataset.
Conclusions There are high rates of association between psychosis and stroke, meaning there is likely a high clinical need group who are under-researched and may be poorly served by existing services. Notably, stroke is a known risk factor for psychosis, and psychosis and antipsychotic treatment for psychosis are known risk factors for stroke, meaning causality is likely to be bidirectional and treatment pathways should be integrated across traditional service boundaries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is a secondary analysis of existing datasets made public by the institutions that collected the data. The relevant ethical approvals are: Adult Psychiatric Morbidity Survey 2007 (UK) The Research Ethics Committee of the Royal Free Hospital and Medical School gave ethical approval for the original study. Collaborative Psychiatric Epidemiology Surveys 2001-2003 (US) The Institutional Review Board of the University of Michigan gave ethical approval for the original study. National Mental Health Survey 2015 (Colombia) The review boards of the the Pontificia Universidad Javeriana and Colciencias gave ethical approval for this study. National Health Survey 2016-2017 (Chile) The ethics committee of the Escuela de Medicina de la Pontificia Universidad Catolica de Chile have ethical approval for this study. Links to all datasets are listed on the github page of the present study: https://github.com/vaughanbell/stroke-psychosis-national-epi-analysis
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Title updated. Abstract updated. Figure removed from paper.
Data Availability
This study is a secondary analysis of existing datasets and so produced no new raw data.
https://github.com/vaughanbell/stroke-psychosis-national-epi-analysis
